Mechanisms Underlying Cancer Progression Caused by Ezrin Overexpression in Tongue Squamous Cell Carcinoma

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Saito, Shota ^a   Yamamoto, Hiroto ^a   Mukaisho, Ken ichi ^a   Sato, Sho ^a   Higo, Tomoki ^a   Hattori, Takanori ^a   Yamamoto, Gaku ^a   Sugihara, Hiroyuki ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; EZRIN; KI 67 ANTIGEN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; PROTEIN CDC42; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UVOMORULIN;

ACTIN FILAMENT; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EZRIN GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TISSUE MICROARRAY; TONGUE CARCINOMA; TUMOR DIFFERENTIATION; UPREGULATION; WESTERN BLOTTING; WOUND HEALING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CYTOSKELETAL PROTEINS; DISEASE PROGRESSION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TONGUE NEOPLASMS;

EID: 84872875596     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054881     Document Type: Article

References (57)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Chandler K, Vance C, Budnick S, Muller S, (2011) Muscle invasion in oral tongue squamous cell carcinoma as a predictor of nodal status and local recurrence: just as effective as depth of invasion? Head Neck Pathol 5: 359-363.
3. Japan Society for Head and Neck Cancer Cancer Registry Committee (2006) Report of Head and Neck Cancer Registry of Japan Clinical Statistics of Registered Patients, 2002. Japanese Journal of Head and Neck Cancer 32 (Suppl): 1-98.
4. Ziober BL, Silverman SS, Kramer RH, (2001) Adhesive mechanisms regulating invasion and metastasis in oral cancer. Crit Rev Oral Biol Med 12: 499-510.
5. Sun CZ, Chen FJ, Zeng ZY, Deng LF, Yang AK, et al. (2006) Treatment and prognostic analysis of 92 cases with advanced mobile tongue squamous cell carcinoma. Zhonghua Kou Qiang Yi Xue Za Zhi 41: 650-653.
6. Jiang H, Liu L, Ye J, Liu H, Xing S, et al. (2010) Focal adhesion kinase serves as a marker of cervical lymph node metastasis and is a potential therapeutic target in tongue cancer. J Cancer Res Clin Oncol 136: 1295-1302.
7. Kruaysawat W, Aekplakorn W, Chapman RS, (2010) Survival time and prognostic factors of oral cancer in Ubon Ratchathani Cancer Center. J Med Assoc Thai 93: 278-284.
8. Wang YH, Wu MW, Yang AK, Zhang WD, Sun J, et al. (2011) COX-2 Gene increases tongue cancer cell proliferation and invasion through VEGF-C pathway. Med Oncol 28Suppl 1: S360-366.
9. Vaheri A, Carpén O, Heiska L, Helander TS, Jääskeläinen J, et al. (1997) The ezrin protein family: membrane-cytoskeleton interactions and disease associations. Curr Opin Cell Biol 9: 659-666.
10. Berryman M, Franck Z, Bretscher A, (1993) Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 105 (Pt 4): 1025-1043.
11. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, (1994) ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126: 391-401.
12. Reczek D, Berryman M, Bretscher A, (1997) Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J Cell Biol 139: 169-179.
13. Bretscher A, Chambers D, Nguyen R, Reczek D, (2000) ERM-Merlin and EBP50 protein families in plasma membrane organization and function. Annu Rev Cell Dev Biol 16: 113-143.
14. Serrador JM, Nieto M, Sánchez-Madrid F, (1999) Cytoskeletal rearrangement during migration and activation of T lymphocytes. Trends Cell Biol 9: 228-233.
15. Ng T, Parsons M, Hughes WE, Monypenny J, Zicha D, et al. (2001) Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility. EMBO J 20: 2723-2741.
16. Bretscher A, Edwards K, Fehon RG, (2002) ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3: 586-599.
17. Wu KL, Khan S, Lakhe-Reddy S, Jarad G, Mukherjee A, et al. (2004) The NHE1 Na+/H+ exchanger recruits ezrin/radixin/moesin proteins to regulate Akt-dependent cell survival. J Biol Chem 279: 26280-26286.
18. McClatchey AI, (2003) Merlin and ERM proteins: unappreciated roles in cancer development? Nat Rev Cancer 3: 877-883.
19. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, et al. (2004) The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10: 182-186.
20. Elliott BE, Meens JA, SenGupta SK, Louvard D, Arpin M, (2005) The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res 7: R365-373.
21. Wang HJ, Zhu JS, Zhang Q, Guo H, Dai YH, et al. (2009) RNAi-mediated silencing of ezrin gene reverses malignant behavior of human gastric cancer cell line SGC-7901. J Dig Dis 10: 258-264.
22. Ling ZQ, Mukaisho K, Yamamoto H, Chen KH, Asano S, et al. (2010) Initiation of malignancy by duodenal contents reflux and the role of ezrin in developing esophageal squamous cell carcinoma. Cancer Sci 101: 624-630.
23. Ferrari S, Zanella L, Alberghini M, Palmerini E, Staals E, et al. (2008) Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma. Pediatr Blood Cancer 50: 752-756.
24. Li Q, Wu M, Wang H, Xu G, Zhu T, et al. (2008) Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells. Cancer Lett 261: 55-63.
25. Shen ZH, Chen XY, Chen J, (2008) Impact of up-regulating Ezrin expression by Epstein-Barr virus latent membrane protein 1 on metastasis ability of nasopharyngeal carcinoma cells. Ai Zheng 27: 165-169.
26. Musiał J, Sporny S, Nowicki A, (2007) Prognostic significance of E-cadherin and ezrin immunohistochemical expression in prostate cancer. Pol J Pathol 58: 235-243.
27. Bruce B, Khanna G, Ren L, Landberg G, Jirström K, et al. (2007) Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis 24: 69-78.
28. Ohtani K, Sakamoto H, Rutherford T, Chen Z, Satoh K, et al. (1999) Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells. Cancer Lett 147: 31-38.
29. Köbel M, Gradhand E, Zeng K, Schmitt WD, Kriese K, et al. (2006) Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma. Int J Gynecol Pathol 25: 121-130.
30. Ilmonen S, Vaheri A, Asko-Seljavaara S, Carpen O, (2005) Ezrin in primary cutaneous melanoma. Mod Pathol 18: 503-510.
31. Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, et al. (2004) Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 10: 175-181.
32. Weng WH, Ahlén J, Aström K, Lui WO, Larsson C, (2005) Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res 11: 6198-6204.
33. Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tanaka T, et al. (2005) The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma. J Oral Pathol Med 34: 602-607.
34. Fischer CA, Jung M, Zlobec I, Green E, Storck C, et al. (2011) Co-overexpression of p21 and Ki-67 in head and neck squamous cell carcinoma relative to a significantly poor prognosis. Head Neck 33: 267-273.
35. Madan R, Brandwein-Gensler M, Schlecht NF, Elias K, Gorbovitsky E, et al. (2006) Differential tissue and subcellular expression of ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic significance for head and neck squamous cell carcinoma. Head Neck 28: 1018-1027.
36. Schlecht NF, Brandwein-Gensler M, Smith RV, Kawachi N, Broughel D, et al. (2012) Cytoplasmic Ezrin and Moesin Correlate with Poor Survival in Head and Neck Squamous Cell Carcinoma. Head Neck Pathol.
37. Zhang Y, Hu MY, Wu WZ, Wang ZJ, Zhou K, et al. (2006) The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness. J Cancer Res Clin Oncol 132: 685-697.
38. Liu SS, Chen XM, Zheng HX, Shi SL, Li Y, (2011) Knockdown of Rab5a expression decreases cancer cell motility and invasion through integrin-mediated signaling pathway. J Biomed Sci 18: 58.
39. Raftopoulou M, Hall A, (2004) Cell migration: Rho GTPases lead the way. Dev Biol 265: 23-32.
40. Turunen O, Wahlström T, Vaheri A, (1994) Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J Cell Biol 126: 1445-1453.
41. Wick W, Grimmel C, Wild-Bode C, Platten M, Arpin M, et al. (2001) Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2. J Neurosci 21: 3360-3368.
42. Curto M, McClatchey AI, (2004) Ezrin..a metastatic detERMinant? Cancer Cell 5: 113-114.
43. Park HR, Jung WW, Bacchini P, Bertoni F, Kim YW, et al. (2006) Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma. Pathol Res Pract 202: 509-515.
44. Kocher HM, Sandle J, Mirza TA, Li NF, Hart IR, (2009) Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells. Gut 58: 271-284.
45. Takeichi M, (1993) Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 5: 806-811.
46. Nagafuchi A, Ishihara S, Tsukita S, (1994) The roles of catenins in the cadherin-mediated cell adhesion: functional analysis of E-cadherin-alpha catenin fusion molecules. J Cell Biol 127: 235-245.
47. Mahomed F, Altini M, Meer S, (2007) Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis. Oral Dis 13: 386-392.
48. Liu LK, Jiang XY, Zhou XX, Wang DM, Song XL, et al. (2010) Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome. Mod Pathol 23: 213-224.
49. Yang S, Guo X, Debnath G, Mohandas N, An X, (2009) Protein 4.1R links E-cadherin/beta-catenin complex to the cytoskeleton through its direct interaction with beta-catenin and modulates adherens junction integrity. Biochim Biophys Acta 1788: 1458-1465.
50. Yamazaki D, Kurisu S, Takenawa T, (2005) Regulation of cancer cell motility through actin reorganization. Cancer Sci 96: 379-386.
51. Hall A, (2005) Rho GTPases and the control of cell behaviour. Biochem Soc Trans 33: 891-895.
52. Huber MA, Kraut N, Beug H, (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558.
53. Christiansen JJ, Rajasekaran AK, (2006) Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66: 8319-8326.
54. Araki K, Shimura T, Suzuki H, Tsutsumi S, Wada W, et al. (2011) E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma. Br J Cancer 105: 1885-1893.
55. Gavert N, Ben-Shmuel A, Lemmon V, Brabletz T, Ben-Ze'ev A, (2010) Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. J Cell Sci 123: 2135-2143.
56. Xie JJ, Xu LY, Xie YM, Zhang HH, Cai WJ, et al. (2009) Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells. Int J Cancer 124: 2549-2558.
57. Sizemore S, Cicek M, Sizemore N, Ng KP, Casey G, (2007) Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin. Cancer Res 67: 6183-6191.